Annual EBITDA
-$289.10 K
+$11.28 M+97.50%
December 31, 2023
Summary
- As of February 7, 2025, SMTI annual EBITDA is -$289.10 thousand, with the most recent change of +$11.28 million (+97.50%) on December 31, 2023.
- During the last 3 years, SMTI annual EBITDA has risen by +$3.85 million (+93.02%).
- SMTI annual EBITDA is now -153.66% below its all-time high of $538.80 thousand, reached on December 31, 2017.
Performance
SMTI EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$851.60 K
+$927.70 K+52.14%
September 30, 2024
Summary
- As of February 7, 2025, SMTI quarterly EBITDA is -$851.60 thousand, with the most recent change of +$927.70 thousand (+52.14%) on September 30, 2024.
- Over the past year, SMTI quarterly EBITDA has dropped by -$942.60 thousand (-1035.82%).
- SMTI quarterly EBITDA is now -154.44% below its all-time high of $1.56 million, reached on December 31, 2011.
Performance
SMTI Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$1.94 M
-$942.60 K-94.75%
September 30, 2024
Summary
- As of February 7, 2025, SMTI TTM EBITDA is -$1.94 million, with the most recent change of -$942.60 thousand (-94.75%) on September 30, 2024.
- Over the past year, SMTI TTM EBITDA has increased by +$2.82 million (+59.28%).
- SMTI TTM EBITDA is now -183.86% below its all-time high of $2.31 million, reached on June 30, 2012.
Performance
SMTI TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
SMTI EBITDA Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +97.5% | -1035.8% | +59.3% |
3 y3 years | +93.0% | +19.9% | +73.3% |
5 y5 years | +32.8% | +19.9% | +73.3% |
SMTI EBITDA Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +97.5% | -176.1% | +74.6% | -596.9% | +83.3% |
5 y | 5-year | at high | +97.5% | -176.1% | +74.6% | -596.9% | +83.3% |
alltime | all time | -153.7% | +97.5% | -154.4% | +77.9% | -183.9% | +83.3% |
Sanara MedTech EBITDA History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | -$851.60 K(-52.1%) | -$1.94 M(+94.8%) |
Jun 2024 | - | -$1.78 M(+317.4%) | -$994.80 K(+257.8%) |
Mar 2024 | - | -$426.30 K(-138.1%) | -$278.00 K(-3.8%) |
Dec 2023 | -$289.10 K(-97.5%) | $1.12 M(+1130.5%) | -$289.10 K(-93.9%) |
Sep 2023 | - | $91.00 K(-108.6%) | -$4.76 M(-34.5%) |
Jun 2023 | - | -$1.06 M(+142.9%) | -$7.27 M(-19.7%) |
Mar 2023 | - | -$437.40 K(-86.9%) | -$9.05 M(-21.8%) |
Dec 2022 | -$11.57 M(+56.4%) | -$3.35 M(+38.6%) | -$11.57 M(-0.1%) |
Sep 2022 | - | -$2.42 M(-15.1%) | -$11.57 M(+5.2%) |
Jun 2022 | - | -$2.85 M(-3.7%) | -$11.00 M(+18.8%) |
Mar 2022 | - | -$2.95 M(-12.0%) | -$9.26 M(+25.2%) |
Dec 2021 | -$7.40 M(+78.6%) | -$3.36 M(+82.0%) | -$7.40 M(+75.1%) |
Sep 2021 | - | -$1.84 M(+66.8%) | -$4.22 M(+20.5%) |
Jun 2021 | - | -$1.11 M(+1.2%) | -$3.51 M(+1.5%) |
Mar 2021 | - | -$1.09 M(+493.2%) | -$3.46 M(-16.6%) |
Dec 2020 | -$4.14 M(+58.7%) | -$184.10 K(-83.6%) | -$4.14 M(-22.8%) |
Sep 2020 | - | -$1.12 M(+6.7%) | -$5.36 M(+7.5%) |
Jun 2020 | - | -$1.05 M(-40.7%) | -$4.99 M(+17.8%) |
Mar 2020 | - | -$1.78 M(+26.6%) | -$4.24 M(+62.3%) |
Dec 2019 | -$2.61 M(+506.8%) | -$1.41 M(+87.0%) | -$2.61 M(+58.0%) |
Sep 2019 | - | -$751.50 K(+150.2%) | -$1.65 M(+61.4%) |
Jun 2019 | - | -$300.40 K(+96.6%) | -$1.02 M(+52.8%) |
Mar 2019 | - | -$152.80 K(-65.8%) | -$669.90 K(+55.8%) |
Dec 2018 | -$430.10 K(-179.8%) | -$447.40 K(+264.6%) | -$430.00 K(-256.4%) |
Sep 2018 | - | -$122.70 K(-331.5%) | $274.90 K(-33.0%) |
Jun 2018 | - | $53.00 K(-39.2%) | $410.20 K(-19.2%) |
Mar 2018 | - | $87.10 K(-66.2%) | $507.90 K(-5.7%) |
Dec 2017 | $538.80 K(-398.7%) | $257.50 K(+1943.7%) | $538.80 K(-6.0%) |
Sep 2017 | - | $12.60 K(-91.6%) | $573.30 K(-28.3%) |
Jun 2017 | - | $150.70 K(+27.7%) | $799.90 K(-469.6%) |
Mar 2017 | - | $118.00 K(-59.6%) | -$216.40 K(+20.0%) |
Dec 2016 | -$180.40 K(-83.7%) | $292.00 K(+22.1%) | -$180.30 K(-78.8%) |
Sep 2016 | - | $239.20 K(-127.6%) | -$851.10 K(-29.5%) |
Jun 2016 | - | -$865.60 K(-661.7%) | -$1.21 M(+38.9%) |
Mar 2016 | - | $154.10 K(-140.7%) | -$868.60 K(-21.3%) |
Dec 2015 | -$1.10 M(-42.8%) | -$378.80 K(+225.2%) | -$1.10 M(+15.4%) |
Sep 2015 | - | -$116.50 K(-77.9%) | -$956.40 K(-33.9%) |
Jun 2015 | - | -$527.40 K(+552.7%) | -$1.45 M(-11.7%) |
Mar 2015 | - | -$80.80 K(-65.1%) | -$1.64 M(-14.9%) |
Dec 2014 | -$1.93 M(-16.5%) | -$231.70 K(-61.9%) | -$1.93 M(-8.6%) |
Sep 2014 | - | -$607.90 K(-15.5%) | -$2.11 M(-21.3%) |
Jun 2014 | - | -$719.40 K(+95.1%) | -$2.68 M(+56.8%) |
Mar 2014 | - | -$368.80 K(-10.9%) | -$1.71 M(-20.2%) |
Dec 2013 | -$2.31 M | -$413.90 K(-64.9%) | -$2.14 M(+1.5%) |
Sep 2013 | - | -$1.18 M(-569.1%) | -$2.11 M(+4.2%) |
Jun 2013 | - | $251.20 K(-131.4%) | -$2.02 M(+3.5%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2013 | - | -$801.00 K(+109.9%) | -$1.96 M(+238.8%) |
Dec 2012 | -$566.90 K(-89.6%) | -$381.60 K(-65.1%) | -$577.20 K(-142.2%) |
Sep 2012 | - | -$1.09 M(-441.9%) | $1.37 M(-40.8%) |
Jun 2012 | - | $319.60 K(-44.6%) | $2.31 M(-245.8%) |
Mar 2012 | - | $577.40 K(-63.1%) | -$1.59 M(-73.7%) |
Dec 2011 | -$5.46 M(+2.5%) | $1.56 M(-1135.3%) | -$6.02 M(-40.9%) |
Sep 2011 | - | -$151.10 K(-95.8%) | -$10.17 M(-9.6%) |
Jun 2011 | - | -$3.58 M(-7.2%) | -$11.25 M(+38.1%) |
Mar 2011 | - | -$3.85 M(+48.7%) | -$8.15 M(+52.9%) |
Dec 2010 | -$5.33 M(+120.4%) | -$2.59 M(+110.6%) | -$5.33 M(+25.9%) |
Sep 2010 | - | -$1.23 M(+162.2%) | -$4.23 M(+31.0%) |
Jun 2010 | - | -$469.40 K(-54.7%) | -$3.23 M(+7.8%) |
Mar 2010 | - | -$1.04 M(-30.7%) | -$3.00 M(+23.5%) |
Dec 2009 | -$2.42 M(+45.5%) | -$1.49 M(+550.3%) | -$2.43 M(+40.5%) |
Sep 2009 | - | -$229.80 K(-2.7%) | -$1.73 M(-5.8%) |
Jun 2009 | - | -$236.10 K(-49.3%) | -$1.83 M(+2.5%) |
Mar 2009 | - | -$466.10 K(-41.4%) | -$1.79 M(+6.6%) |
Dec 2008 | -$1.66 M(+331.0%) | -$795.10 K(+135.9%) | -$1.68 M(+57.1%) |
Sep 2008 | - | -$337.00 K(+75.8%) | -$1.07 M(+30.5%) |
Jun 2008 | - | -$191.70 K(-46.1%) | -$819.50 K(+37.0%) |
Mar 2008 | - | -$355.50 K(+92.2%) | -$598.10 K(+55.1%) |
Dec 2007 | -$385.70 K(-17.2%) | -$185.00 K(+111.9%) | -$385.60 K(+13.4%) |
Sep 2007 | - | -$87.30 K(-393.9%) | -$340.00 K(-4.3%) |
Jun 2007 | - | $29.70 K(-120.8%) | -$355.30 K(-28.9%) |
Mar 2007 | - | -$143.00 K(+2.6%) | -$499.70 K(+6.6%) |
Dec 2006 | -$466.10 K(-35.7%) | -$139.40 K(+35.9%) | -$468.60 K(+5.9%) |
Sep 2006 | - | -$102.60 K(-10.5%) | -$442.50 K(-1.6%) |
Jun 2006 | - | -$114.70 K(+2.5%) | -$449.90 K(-31.8%) |
Mar 2006 | - | -$111.90 K(-1.2%) | -$659.90 K(-7.8%) |
Dec 2005 | -$724.60 K(-56.3%) | -$113.30 K(+3.0%) | -$715.60 K(-11.2%) |
Sep 2005 | - | -$110.00 K(-66.1%) | -$805.60 K(-48.2%) |
Jun 2005 | - | -$324.70 K(+93.7%) | -$1.55 M(+25.9%) |
Mar 2005 | - | -$167.60 K(-17.6%) | -$1.23 M(+19.1%) |
Dec 2004 | -$1.66 M(+19.6%) | -$203.30 K(-76.3%) | -$1.04 M(+24.4%) |
Sep 2004 | - | -$858.80 K(>+9900.0%) | -$832.90 K(-3315.8%) |
Jun 2004 | - | -$4600.00(-115.1%) | $25.90 K(-15.1%) |
Mar 2004 | - | $30.50 K(-111.4%) | $30.50 K(-101.8%) |
Mar 2002 | - | -$267.70 K(-74.3%) | -$1.67 M(+20.7%) |
Dec 2001 | -$1.39 M(+68.4%) | -$1.04 M(+294.8%) | -$1.39 M(+121.8%) |
Sep 2001 | - | -$264.10 K(+167.3%) | -$624.80 K(+16.7%) |
Jun 2001 | - | -$98.80 K(-606.7%) | -$535.60 K(-27.0%) |
Mar 2001 | - | $19.50 K(-106.9%) | -$734.10 K(-1.4%) |
Dec 2000 | -$823.50 K(+6.6%) | -$281.40 K(+60.9%) | -$744.60 K(+60.8%) |
Sep 2000 | - | -$174.90 K(-41.2%) | -$463.20 K(+60.7%) |
Jun 2000 | - | -$297.30 K(-3403.3%) | -$288.30 K(-3303.3%) |
Mar 2000 | - | $9000.00 | $9000.00 |
Dec 1999 | -$772.80 K | - | - |
FAQ
- What is Sanara MedTech annual EBITDA?
- What is the all time high annual EBITDA for Sanara MedTech?
- What is Sanara MedTech annual EBITDA year-on-year change?
- What is Sanara MedTech quarterly EBITDA?
- What is the all time high quarterly EBITDA for Sanara MedTech?
- What is Sanara MedTech quarterly EBITDA year-on-year change?
- What is Sanara MedTech TTM EBITDA?
- What is the all time high TTM EBITDA for Sanara MedTech?
- What is Sanara MedTech TTM EBITDA year-on-year change?
What is Sanara MedTech annual EBITDA?
The current annual EBITDA of SMTI is -$289.10 K
What is the all time high annual EBITDA for Sanara MedTech?
Sanara MedTech all-time high annual EBITDA is $538.80 K
What is Sanara MedTech annual EBITDA year-on-year change?
Over the past year, SMTI annual EBITDA has changed by +$11.28 M (+97.50%)
What is Sanara MedTech quarterly EBITDA?
The current quarterly EBITDA of SMTI is -$851.60 K
What is the all time high quarterly EBITDA for Sanara MedTech?
Sanara MedTech all-time high quarterly EBITDA is $1.56 M
What is Sanara MedTech quarterly EBITDA year-on-year change?
Over the past year, SMTI quarterly EBITDA has changed by -$942.60 K (-1035.82%)
What is Sanara MedTech TTM EBITDA?
The current TTM EBITDA of SMTI is -$1.94 M
What is the all time high TTM EBITDA for Sanara MedTech?
Sanara MedTech all-time high TTM EBITDA is $2.31 M
What is Sanara MedTech TTM EBITDA year-on-year change?
Over the past year, SMTI TTM EBITDA has changed by +$2.82 M (+59.28%)